相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells
Anil Kumar et al.
DRUG DELIVERY (2016)
GLIOMA IN 2014 Unravelling tumour heterogeneity -implications for therapy
David A. Reardon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The oral bioavailability of curcuminoids in healthy humans is markedly enhanced by micellar solubilisation but not further improved by simultaneous ingestion of sesamin, ferulic acid, naringenin and xanthohumol
Alexa Kocher et al.
JOURNAL OF FUNCTIONAL FOODS (2015)
A Urokinase Receptor-Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma
Jill Wykosky et al.
CANCER RESEARCH (2015)
Simple and effective preparation of nano-pulverized curcumin by femtosecond laser ablation and the cytotoxic effect on C6 rat glioma cells in vitro
Tatsuaki Tagami et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
Christina Schiborr et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Hybrid Curcumin Compounds: A New Strategy for Cancer Treatment
Marie-Helene Teiten et al.
MOLECULES (2014)
Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
David A. Nathanson et al.
SCIENCE (2014)
Rethinking glioma treatment strategy
Tatsuya Ozawa et al.
ONCOTARGET (2014)
ROS-dependent prostate apoptosis response-4 (Par-4) up-regulation and ceramide generation are the prime signaling events associated with curcumin-induced autophagic cell death in human malignant glioma
Faisal Thayyullathil et al.
FEBS OPEN BIO (2014)
Curcumin Suppresses Malignant Glioma Cells Growth and Induces Apoptosis by Inhibition of SHH/GLI1 Signaling Pathway in Vitro and Vivo
Wen-Zhong Du et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment
Alfeu Zanotto-Filho et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy
Elke Hattingen et al.
PLOS ONE (2013)
Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy
Wenzhuo Zhuang et al.
CANCER SCIENCE (2012)
Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells
Junfei Shao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
1H magnetic resonance spectroscopy metabolites as biomarkers for cell cycle arrest and cell death in rat glioma cells
Ladan Mirbahai et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Preparation of curcumin loaded poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells
Gang Guo et al.
NANOSCALE (2011)
Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study
Elke Hattingen et al.
NEURO-ONCOLOGY (2011)
A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection
Christina Schiborr et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas
Christian Senft et al.
BMC CANCER (2010)
Dietary Curcumin Attenuates Glioma Growth in a Syngeneic Mouse Model by Inhibition of the JAK1,2/STAT3 Signaling Pathway
Jakob Weissenberger et al.
CLINICAL CANCER RESEARCH (2010)
Safety and Pharmacokinetics of a Solid Lipid Curcumin Particle Formulation in Osteosarcoma Patients and Healthy Volunteers
Vikram S. Gota et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Chemoradiotherapy in malignant glioma: Standard of care and future directions
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells
Kristine Glunde et al.
NEOPLASIA (2006)
Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice
BB Aggarwal et al.
CLINICAL CANCER RESEARCH (2005)
Curcumin in plasma and urine: quantitation by high-performance liquid chromatography
DD Heath et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl
RJ Anto et al.
CARCINOGENESIS (2002)
分享论文
